Skip To Main Content
Susan Samson on Muck Rack

Susan Samson

As seen in: MDPI, Cell Press, MedPage Today, Edmonton Journal, Healio, Endocrine Today, Healio Primary Care, HCP Live, Future Medicine, Medical Economics and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Susan

Contact Susan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

From Label to Etiology: Applying the 2026 AACE Framework

|
By Susan Samson, Guillermo E. Umpierrez
| consultantlive.com
Beyond Type 2: Classifying Diabetes and Screening for Hypercortisolism in the 2026 AACE Algorithm - Episode 6 Published on: , Learn how clinicians spot uncommon diabetes causes—from pancreatic disease and MODY to steroids, transplants, and checkpoint inhibitors—before treatment.
Open in Who Shared Issue with article?

How the 2026 AACE Algorithm Broadens the Lens on Diabetes

|
By Susan Samson, Guillermo E. Umpierrez
| consultantlive.com
Experts outline the broader differential diagnosis embedded in the new algorithm, spanning pancreatic, monogenic, treatment-related, and rare genetic forms of diabetes that may masquerade as type 2 in adults. In this section, Samson invites Umpierrez to walk through the remaining categories included in the 2026 AACE diabetes classification algorithm beyond autoimmune diabetes and hypercortisolism.
Open in Who Shared Issue with article?

Hypercortisolism in Refractory Diabetes, CATALYST Data

|
By Susan Samson, Guillermo E. Umpierrez
| consultantlive.com
Beyond Type 2: Classifying Diabetes and Screening for Hypercortisolism in the 2026 AACE Algorithm - Episode 4 Published on: , Learn key clues that diabetes isn’t type 2, and how autoantibody tests plus C‑peptide guide accurate adult type 1/LADA diagnosis. Experts examine the role of hypercortisolism in difficult-to-control diabetes, highlighting findings from the CATALYST trial and the practical implications of dexamethasone suppression testing in this population.
Open in Who Shared Issue with article?
See all 18 licensed articles (26 Total)